Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
AACR 2026
EBCC15
2026 ASCO GU
2026 ASCO GI
SUO 2025
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN 2018 Annual Conference,NCCN 2018 Annual Conference
«
1
»
Advertisement
Advertisement
Apr
23
Today In Oncology
Overall Survival With Addition of Relacorilant to Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer
Tislelizumab With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Perioperative Pembrolizumab in Localized Colorectal Cancer With dMMR/MSI
AMA Data Shows Nearly 50 Percent of Surveyed Oncologists Reported Burnout in 2025
Long-Term Immunotherapy for Alveolar Soft Part Sarcoma
View More
Advertisement
